Your browser doesn't support javascript.
loading
Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization.
Rahman, Rifaquat; Trippa, Lorenzo; Lee, Eudocia Q; Arrillaga-Romany, Isabel; Fell, Geoffrey; Touat, Mehdi; McCluskey, Christine; Wiley, Jennifer; Gaffey, Sarah; Drappatz, Jan; Welch, Mary R; Galanis, Evanthia; Ahluwalia, Manmeet S; Colman, Howard; Nabors, L Burt; Hepel, Jaroslaw; Elinzano, Heinrich; Schiff, David; Chukwueke, Ugonma N; Beroukhim, Rameen; Nayak, Lakshmi; McFaline-Figueroa, J Ricardo; Batchelor, Tracy T; Rinne, Mikael L; Kaley, Thomas J; Lu-Emerson, Christine; Mellinghoff, Ingo K; Bi, Wenya Linda; Arnaout, Omar; Peruzzi, Pier Paolo; Haas-Kogan, Daphne; Tanguturi, Shyam; Cagney, Daniel; Aizer, Ayal; Doherty, Lisa; Lavallee, Maria; Fisher-Longden, Brittany; Dowling, Shanna; Geduldig, Jack; Watkinson, Fiona; Pisano, William; Malinowski, Seth; Ramkissoon, Shakti; Santagata, Sandro; Meredith, David M; Chiocca, E Antonio; Reardon, David A; Alexander, Brian M; Ligon, Keith L; Wen, Patrick Y.
Afiliación
  • Rahman R; Dana-Farber Cancer Institute, Boston, MA.
  • Trippa L; Brigham and Women's Hospital, Boston, MA.
  • Lee EQ; Dana-Farber Cancer Institute, Boston, MA.
  • Arrillaga-Romany I; Dana-Farber Cancer Institute, Boston, MA.
  • Fell G; Brigham and Women's Hospital, Boston, MA.
  • Touat M; Massachusetts General Hospital, Boston, MA.
  • McCluskey C; Dana-Farber Cancer Institute, Boston, MA.
  • Wiley J; Brigham and Women's Hospital, Boston, MA.
  • Gaffey S; Sorbonne Universite, Hôpitaux Universitaires La Pitié Salpêtrière, Paris, France.
  • Drappatz J; Dana-Farber Cancer Institute, Boston, MA.
  • Welch MR; Dana-Farber Cancer Institute, Boston, MA.
  • Galanis E; Dana-Farber Cancer Institute, Boston, MA.
  • Ahluwalia MS; University of Pittsburgh, Pittsburgh, PA.
  • Colman H; Division of Neuro-Oncology, Department of Neurology and Herbert Irving Comprehensive Cancer Center, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian, New York, NY.
  • Nabors LB; Mayo Clinic, Rochester, MN.
  • Hepel J; Miami Cancer Institute, Miami, FL.
  • Elinzano H; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
  • Schiff D; University of Alabama at Birmingham, Birmingham, AL.
  • Chukwueke UN; Rhode Island Hospital, Providence, RI.
  • Beroukhim R; Rhode Island Hospital, Providence, RI.
  • Nayak L; University of Virginia, Charlottesville, VA.
  • McFaline-Figueroa JR; Dana-Farber Cancer Institute, Boston, MA.
  • Batchelor TT; Brigham and Women's Hospital, Boston, MA.
  • Rinne ML; Dana-Farber Cancer Institute, Boston, MA.
  • Kaley TJ; Brigham and Women's Hospital, Boston, MA.
  • Lu-Emerson C; Dana-Farber Cancer Institute, Boston, MA.
  • Mellinghoff IK; Brigham and Women's Hospital, Boston, MA.
  • Bi WL; Dana-Farber Cancer Institute, Boston, MA.
  • Arnaout O; Brigham and Women's Hospital, Boston, MA.
  • Peruzzi PP; Dana-Farber Cancer Institute, Boston, MA.
  • Haas-Kogan D; Brigham and Women's Hospital, Boston, MA.
  • Tanguturi S; Dana-Farber Cancer Institute, Boston, MA.
  • Cagney D; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Aizer A; Maine Medical Center, Portland, ME.
  • Doherty L; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Lavallee M; Dana-Farber Cancer Institute, Boston, MA.
  • Fisher-Longden B; Brigham and Women's Hospital, Boston, MA.
  • Dowling S; Brigham and Women's Hospital, Boston, MA.
  • Geduldig J; Brigham and Women's Hospital, Boston, MA.
  • Watkinson F; Dana-Farber Cancer Institute, Boston, MA.
  • Pisano W; Brigham and Women's Hospital, Boston, MA.
  • Malinowski S; Dana-Farber Cancer Institute, Boston, MA.
  • Ramkissoon S; Brigham and Women's Hospital, Boston, MA.
  • Santagata S; Mater Private, Dublin, Ireland.
  • Meredith DM; Dana-Farber Cancer Institute, Boston, MA.
  • Chiocca EA; Brigham and Women's Hospital, Boston, MA.
  • Reardon DA; Dana-Farber Cancer Institute, Boston, MA.
  • Alexander BM; Dana-Farber Cancer Institute, Boston, MA.
  • Ligon KL; Dana-Farber Cancer Institute, Boston, MA.
  • Wen PY; Dana-Farber Cancer Institute, Boston, MA.
J Clin Oncol ; 41(36): 5524-5535, 2023 Dec 20.
Article en En | MEDLINE | ID: mdl-37722087
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Marruecos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Marruecos Pais de publicación: Estados Unidos